Scarica l'app Stockscreener
11.70
2.74%
-0.33
Precedente Chiudi:
$12.03
Aprire:
$12.24
Volume 24 ore:
221.21K
Relative Volume:
0.93
Capitalizzazione di mercato:
$469.69M
Reddito:
$822.31M
Utile/perdita netta:
$-92.19M
Rapporto P/E:
-5.00
EPS:
-2.34
Flusso di cassa netto:
$-1.32M
1 W Prestazione:
-7.29%
1M Prestazione:
-12.56%
6M Prestazione:
-21.53%
1 anno Prestazione:
-28.22%
Intervallo 1D:
$11.68
$12.24
Intervallo di 1 settimana:
$11.68
$12.65
Portata 52W:
$10.24
$17.00
Orthofix Medical Inc Stock (OFIX) Company Profile
Nome
Orthofix Medical Inc
Settore
Industria
Telefono
214-937-2000
Indirizzo
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
11.70 | 469.69M | 822.31M | -92.19M | -1.32M | -2.34 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | TD Cowen | Hold |
| 2025-10-28 | Ripresa | Stifel | Buy |
| 2025-01-22 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-08 | Aggiornamento | Stifel | Hold → Buy |
| 2024-05-08 | Aggiornamento | ROTH MKM | Neutral → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-09-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-09-12 | Downgrade | Stifel | Buy → Hold |
| 2023-07-19 | Ripresa | BTIG Research | Buy |
| 2022-03-04 | Aggiornamento | Stifel | Hold → Buy |
| 2020-10-20 | Iniziato | Stifel | Hold |
| 2019-10-29 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-06-21 | Iniziato | BTIG Research | Buy |
| 2017-06-14 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-05-23 | Iniziato | SunTrust | Buy |
| 2015-07-10 | Iniziato | Sidoti | Buy |
| 2013-05-09 | Downgrade | Mizuho | Buy → Neutral |
| 2013-01-08 | Reiterato | Mizuho | Buy |
| 2010-06-21 | Iniziato | Boenning & Scattergood | Outperform |
| 2010-03-09 | Reiterato | Jefferies & Co | Buy |
| 2010-02-18 | Aggiornamento | Susquehanna Financial | Neutral → Positive |
| 2010-01-22 | Iniziato | Jefferies & Co | Buy |
| 2009-11-03 | Aggiornamento | Wells Fargo | Underperform → Market Perform |
| 2009-07-31 | Reiterato | Jefferies & Co | Buy |
| 2009-07-31 | Aggiornamento | Thomas Weisel | Market Weight → Overweight |
| 2009-05-26 | Reiterato | Jefferies & Co | Buy |
| 2009-04-17 | Downgrade | Wachovia | Mkt Perform → Underperform |
| 2009-02-19 | Iniziato | Canaccord Adams | Buy |
| 2008-07-07 | Downgrade | Wachovia | Outperform → Mkt Perform |
Mostra tutto
Orthofix Medical Inc Borsa (OFIX) Ultime notizie
Orthofix Medical Inc Stock (ISIN: US6875231068) Faces Margin Pressure as Spine Segment Growth Slows - AD HOC NEWS
Orthofix Medical (OFIX) Narrative Shifts As Analysts Recut Targets And Profitability Timelines - Yahoo Finance
Is Orthofix Medical Inc. stock affected by interest rate hikesQuarterly Profit Review & Reliable Volume Spike Alerts - mfd.ru
Stifel cuts Orthofix stock price target on mixed results By Investing.com - Investing.com Nigeria
Orthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence - GlobeNewswire Inc.
Orthofix Medical Inc. Q4 2025 earnings preview - MSN
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal
OFIX Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical Inc. – OFIX - bdtonline.com
Insider Buying: Vickie Capps Acquires 5,000 Shares of Orthofix M - GuruFocus
Orthofix Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical, Inc. – OFIX - Bluefield Daily Telegraph
FinancialContentOrthofix Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical, Inc. – OFIX - FinancialContent
Orthofix medical CP&BOO Vitale Lucas sells $29k in stock - Investing.com Nigeria
Responsive Playbooks and the OFIX Inflection - Stock Traders Daily
A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts - Benzinga
Orthofix Medical (NASDAQ:OFIX) Price Target Cut to $18.00 by Analysts at Stifel Nicolaus - MarketBeat
Stifel cuts Orthofix stock price target on mixed results - Investing.com
Volatility Watch: Can Orthofix Medical Inc disrupt its industry2026 Earnings Surprises & Daily Entry Point Alerts - baoquankhu1.vn
Short Covering: What is Orthofix Medical Incs revenue forecastJuly 2025 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Can Orthofix Medical Inc. stock resist sector downturns2025 Fundamental Recap & Weekly Breakout Watchlists - Naître et grandir
Orthofix Medical (NASDAQ:OFIX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Orthofix medical CP&BOO Vitale Lucas sells $29k in stock By Investing.com - Investing.com India
Orthofix medical CLO Cedron sells $35k in OFIX stock - Investing.com
Orthofix medical CLO Cedron sells $35k in OFIX stock By Investing.com - Investing.com India
Orthofix Medical (OFIX) exec sells shares for RSU tax cover - Stock Titan
Orthofix (OFIX) CEO logs 12,220-share tax sell-to-cover, keeps 320,136 shares - Stock Titan
Orthofix (OFIX) CEO receives major stock and option awards - Stock Titan
Fitbone™ Product Expansion in Limb Reconstruction - Orthopedics This Week
Fitbone™ Trochanteric Lengthening System Launches Commercially in the U.S. Expanding Precision Options for Internal Limb Reconstruction - Ortho Spine News
Orthofix at TD Cowen Conference: Strategic Growth and Innovation - Investing.com
Orthofix at TD Cowen Conference: Strategic Growth and Innovation By Investing.com - Investing.com Canada
Orthofix at 2026 CG Musculoskeletal Conference: Strategic Growth Insights By Investing.com - Investing.com Australia
Orthofix at 2026 CG Musculoskeletal Conference: Strategic Growth Insights - Investing.com India
Orthofix Medical Inc. (OFIX) Target Reduced at Canaccord Following Q4 Results and 2026 Outlook Update - Finviz
Gains Report: What is the earnings history of Orthofix Medical IncJuly 2025 Recap & AI Based Buy and Sell Signals - baoquankhu1.vn
OFIX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Orthofix Medical Inc. (NASDAQ:OFIX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Orthofix Medical (NASDAQ:OFIX) Shares Gap Up Following Insider Buying Activity - MarketBeat
Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring A 38.57% Upside Potential - DirectorsTalk Interviews
Engine Capital Management, Lp Acquires 124,797 Shares of Orthofix Medical (NASDAQ:OFIX) Stock - MarketBeat
Orthofix Medical (NASDAQ:OFIX) Major Shareholder Buys $169,270.56 in Stock - MarketBeat
Orthofix Medical : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Engine capital buys Orthofix (OFIX) shares worth $1.73 million By Investing.com - Investing.com South Africa
Engine capital buys Orthofix (OFIX) shares worth $1.73 million - Investing.com
Engine Capital adds to Orthofix (OFIX) stake with open-market buys - Stock Titan
Orthofix Medical (NASDAQ:OFIX) Price Target Lowered to $20.00 at Canaccord Genuity Group - MarketBeat
Understanding the Setup: (OFIX) and Scalable Risk - Stock Traders Daily
How The Orthofix Medical (OFIX) Narrative Is Shifting With Margin Delays And New 2026 Guidance - Yahoo Finance
OFIX: Barrington Research Lowers Price Target While Maintaining Outperform Rating | OFIX Stock News - GuruFocus
Barrington Research Lowers Orthofix Medical (NASDAQ:OFIX) Price Target to $17.00 - MarketBeat
Barrington Research Adjusts Orthofix Medical PT to $17 From $18, Maintains Outperform Rating - marketscreener.com
Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2025 Earnings Call Transcript - Insider Monkey
Orthofix Medical Inc Azioni (OFIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):